{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:59:57Z","timestamp":1794358797160,"version":"4.9.0"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast cancer is the most prevalent cancer worldwide, and metastasis is the leading cause of death in cancer patients. Human monocyte chemoattractant protein-1 (MCP-1\/CCL2) was isolated from the culture supernatants of not only mitogen-activated peripheral blood mononuclear leukocytes but also malignant glioma cells based on its in vitro chemotactic activity toward human monocytes. MCP-1 was subsequently found to be identical to a previously described tumor cell-derived chemotactic factor thought to be responsible for the accumulation of tumor-associated macrophages (TAMs), and it became a candidate target of clinical intervention; however, the role of TAMs in cancer development was still controversial at the time of the discovery of MCP-1. The in vivo role of MCP-1 in cancer progression was first evaluated by examining human cancer tissues, including breast cancers. Positive correlations between the level of MCP-1 production in tumors and the degree of TAM infiltration and cancer progression were established. The contribution of MCP-1 to the growth of primary tumors and metastasis to the lung, bone, and brain was examined in mouse breast cancer models. The results of these studies strongly suggested that MCP-1 is a promoter of breast cancer metastasis to the lung and brain but not bone. Potential mechanisms of MCP-1 production in the breast cancer microenvironment have also been reported. In the present manuscript, we review studies in which the role of MCP-1 in breast cancer development and progression and the mechanisms of its production were examined and attempt to draw a consensus and discuss the potential use of MCP-1 as a biomarker for diagnosis.<\/jats:p>","DOI":"10.1038\/s41423-023-01013-0","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:02:43Z","timestamp":1684468963000},"page":"714-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3853-2075","authenticated-orcid":false,"given":"Teizo","family":"Yoshimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"1013_CR1","doi-asserted-by":"publisher","first-page":"9233","DOI":"10.1073\/pnas.84.24.9233","volume":"84","author":"T Yoshimura","year":"1987","unstructured":"Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA. 1987;84:9233\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1013_CR2","first-page":"145","volume":"52","author":"PM Murphy","year":"2000","unstructured":"Murphy PM, Baggiolini M, Charo IF, H\u00e9bert CA, Horuk R, Matsushima K, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharm Rev. 2000;52:145\u201376.","journal-title":"Pharm Rev"},{"key":"1013_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","volume":"36","author":"A Zlotnik","year":"2012","unstructured":"Zlotnik A, Yoshie O. The chemokine superfamily revisited. Immunity. 2012;36:705\u201316.","journal-title":"Immunity"},{"key":"1013_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fimmu.2019.00333","volume":"10","author":"AE Vilgelm","year":"2019","unstructured":"Vilgelm AE, Richmond A. Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy. Front Immunol. 2019;10:333.","journal-title":"Front Immunol"},{"key":"1013_CR5","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.3390\/cancers13246317","volume":"13","author":"N Karin","year":"2021","unstructured":"Karin N. Chemokines in the landscape of cancer immunotherapy: How they and their receptors can be used to turn cold tumors into hot ones. Cancers. 2021;13:6317.","journal-title":"Cancers"},{"key":"1013_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga AJ, Chow MT, Luster AD. Chemokines and the immune response to cancer. Immunity. 2021;54:859\u201374.","journal-title":"Immunity"},{"key":"1013_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10555-021-09970-6","volume":"40","author":"S Saxena","year":"2021","unstructured":"Saxena S, Singh RK. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity. Cancer Metastasis Rev. 2021;40:447\u201376.","journal-title":"Cancer Metastasis Rev"},{"key":"1013_CR8","doi-asserted-by":"publisher","first-page":"920779","DOI":"10.3389\/fphar.2022.920779","volume":"13","author":"J Xu","year":"2022","unstructured":"Xu J, Li JQ, Chen QL, Shestakova EA, Misyurin VA, Pokrovsky VS, et al. Advances in research on the effects and mechanisms of chemokines and their receptors in cancer. Front Pharm. 2022;13:920779.","journal-title":"Front Pharm"},{"key":"1013_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/cmi.2017.135","volume":"15","author":"T Yoshimura","year":"2018","unstructured":"Yoshimura T. The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally. Cell Mol Immunol. 2018;15:335\u201345.","journal-title":"Cell Mol Immunol"},{"key":"1013_CR10","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.4049\/jimmunol.142.6.1956","volume":"142","author":"T Yoshimura","year":"1989","unstructured":"Yoshimura T, Robinson EA, Tanaka S, Appella E, Leonard EJ. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J Immunol. 1989;142:1956\u201362.","journal-title":"J Immunol"},{"key":"1013_CR11","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1084\/jem.169.4.1449","volume":"169","author":"T Yoshimura","year":"1989","unstructured":"Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J, Leonard EJ. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med. 1989;169:1449\u201359.","journal-title":"J Exp Med"},{"key":"1013_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/ijc.2910450436","volume":"45","author":"B Bottazzi","year":"1990","unstructured":"Bottazzi B, Colotta F, Sica A, Nobili N, Mantovani A. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1\/monocyte chemotactic and activating factor (MCP-1\/MCAF). Int J Cancer. 1990;45:795\u20137.","journal-title":"Int J Cancer"},{"key":"1013_CR13","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/jnci\/85.22.1836","volume":"85","author":"J Kuratsu","year":"1993","unstructured":"Kuratsu J, Yoshizato K, Yoshimura T, Leonard EJ, Takeshima H, Ushio Y. Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. J Natl Cancer Inst. 1993;85:1836\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"1013_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3171\/jns.1994.80.6.1056","volume":"80","author":"H Takeshima","year":"1994","unstructured":"Takeshima H, Kuratsu J, Takeya M, Yoshimura T, Ushio Y. Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J Neurosurg. 1994;80:1056\u201362.","journal-title":"J Neurosurg"},{"key":"1013_CR15","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3171\/jns.1995.82.5.0874","volume":"82","author":"K Sato","year":"1995","unstructured":"Sato K, Kuratsu J, Takeshima H, Yoshimura T, Ushio Y. Expression of monocyte chemoattractant protein-1 in meningioma. J Neurosurg. 1995;82:874\u20138.","journal-title":"J Neurosurg"},{"key":"1013_CR16","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1172\/JCI117933","volume":"95","author":"RP Negus","year":"1995","unstructured":"Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S, et al. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest. 1995;95:2391\u20136.","journal-title":"J Clin Invest"},{"key":"1013_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s002620050603","volume":"49","author":"DA Arenberg","year":"2000","unstructured":"Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Strom SR, Burdick MD, et al. Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother. 2000;49:63\u201370.","journal-title":"Cancer Immunol Immunother"},{"key":"1013_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/path.1711720302","volume":"172","author":"C O\u2019Sullivan","year":"1994","unstructured":"O\u2019Sullivan C, Lewis CE. Tumour-associated leucocytes: friends or foes in breast carcinoma. J Pathol. 1994;172:229\u201335.","journal-title":"J Pathol"},{"key":"1013_CR19","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1084\/jem.171.6.2177","volume":"171","author":"CO Zachariae","year":"1990","unstructured":"Zachariae CO, Anderson AO, Thompson HL, Appella E, Mantovani A, Oppenheim JJ, et al. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med. 1990;171:2177\u201382.","journal-title":"J Exp Med"},{"key":"1013_CR20","first-page":"3125","volume":"11","author":"BJ Rollins","year":"1991","unstructured":"Rollins BJ, Sunday ME. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol Cell Biol. 1991;11:3125\u201331.","journal-title":"Mol Cell Biol"},{"key":"1013_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ijc.2910490321","volume":"49","author":"S Walter","year":"1991","unstructured":"Walter S, Bottazzi B, Govoni D, Colotta F, Mantovani A. Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein\/JE. Int J Cancer. 1991;49:431\u20135.","journal-title":"Int J Cancer"},{"key":"1013_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF01516997","volume":"41","author":"Y Manome","year":"1995","unstructured":"Manome Y, Wen PY, Hershowitz A, Tanaka T, Rollins BJ, Kufe DW, et al. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol Immunother. 1995;41:227\u201335.","journal-title":"Cancer Immunol Immunother"},{"key":"1013_CR23","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1023\/A:1016276613684","volume":"12","author":"E Nakashima","year":"1995","unstructured":"Nakashima E, Mukaida N, Kubota Y, Kuno K, Yasumoto K, Ichimura F, et al. Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo. Pharm Res. 1995;12:1598\u2013604.","journal-title":"Pharm Res"},{"key":"1013_CR24","doi-asserted-by":"publisher","first-page":"8530","DOI":"10.3390\/ijms22168530","volume":"22","author":"S Kadomoto","year":"2021","unstructured":"Kadomoto S, Izumi K, Mizokami A. Roles of CCL2-CCR2 axis in the tumor microenvironment. Int J Mol Sci. 2021;22:8530.","journal-title":"Int J Mol Sci"},{"key":"1013_CR25","first-page":"23","volume":"9","author":"X Jin","year":"2015","unstructured":"Jin X, Mu P. Targeting breast cancer metastasis. Breast Cancer. 2015;9:23\u201334.","journal-title":"Breast Cancer"},{"key":"1013_CR26","doi-asserted-by":"crossref","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149:778\u201389.","DOI":"10.1002\/ijc.33588"},{"key":"1013_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41416-021-01328-7","volume":"125","author":"F L\u00fc\u00f6nd","year":"2021","unstructured":"L\u00fc\u00f6nd F, Tiede S, Christofori G. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression. Br J Cancer. 2021;125:164\u201375.","journal-title":"Br J Cancer"},{"key":"1013_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","volume":"12","author":"A Zlotnik","year":"2000","unstructured":"Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121\u20137.","journal-title":"Immunity"},{"key":"1013_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0344-0338(98)80057-5","volume":"194","author":"T Valkovi\u0107","year":"1998","unstructured":"Valkovi\u0107 T, Lucin K, Krstulja M, Dobi-Babi\u0107 R, Jonji\u0107 N. Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol Res Pr. 1998;194:335\u201340.","journal-title":"Pathol Res Pr"},{"key":"1013_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00432-004-0667-3","volume":"131","author":"T Valkovi\u0107","year":"2005","unstructured":"Valkovi\u0107 T, Fuckar D, Stifter S, Matusan K, Hasan M, Dobrila F, et al. Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma. J Cancer Res Clin Oncol. 2005;131:453\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1013_CR31","first-page":"3282","volume":"6","author":"T Ueno","year":"2000","unstructured":"Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res. 2000;6:3282\u20139.","journal-title":"Clin Cancer Res"},{"key":"1013_CR32","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K","volume":"92","author":"H Saji","year":"2001","unstructured":"Saji H, Koike M, Yamori T, Saji S, Seiki M, Matsushima K, et al. Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer. 2001;92:1085\u201391.","journal-title":"Cancer"},{"key":"1013_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1648","volume":"9","author":"C Chavey","year":"2007","unstructured":"Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissi\u00e8re F, Laune D, et al. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res. 2007;9:R15.","journal-title":"Breast Cancer Res"},{"key":"1013_CR34","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/ijc.24378","volume":"125","author":"H Fujimoto","year":"2009","unstructured":"Fujimoto H, Sangai T, Ishii G, Ikehara A, Nagashima T, Miyazaki M, et al. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int J Cancer. 2009;125:1276\u201384.","journal-title":"Int J Cancer"},{"key":"1013_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-130","volume":"11","author":"G Soria","year":"2011","unstructured":"Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, et al. Inflammatory mediators in breast cancer: coordinated expression of TNF\u03b1 & IL-1\u03b2 with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer. 2011;11:130.","journal-title":"BMC Cancer"},{"key":"1013_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13287-015-0080-7","volume":"6","author":"C Katanov","year":"2015","unstructured":"Katanov C, Lerrer S, Liubomirski Y, Leider-Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-\u03b1 and the NF-\u03baB pathway. Stem Cell Res Ther. 2015;6:87.","journal-title":"Stem Cell Res Ther"},{"key":"1013_CR37","first-page":"15684","volume":"8","author":"J Wang","year":"2015","unstructured":"Wang J, Zhuang ZG, Xu SF, He Q, Shao YG, Ji M, et al. Expression of CCL2 is significantly different in five breast cancer genotypes and predicts patient outcome. Int J Clin Exp Med. 2015;8:15684\u201391.","journal-title":"Int J Clin Exp Med"},{"key":"1013_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cas.14230","volume":"111","author":"D Li","year":"2020","unstructured":"Li D, Ji H, Niu X, Yin L, Wang Y, Gu Y, et al. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K\/Akt\/mTOR in breast cancer. Cancer Sci. 2020;111:47\u201358.","journal-title":"Cancer Sci"},{"key":"1013_CR39","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389:1134\u201350.","journal-title":"Lancet"},{"key":"1013_CR40","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.neo.2014.09.004","volume":"16","author":"EG Mathenge","year":"2014","unstructured":"Mathenge EG, Dean CA, Clements D, Vaghar-Kashani A, Photopoulos S, Coyle KM, et al. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model. Neoplasia. 2014;16:950\u201360.","journal-title":"Neoplasia"},{"key":"1013_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/onco2010001","volume":"2","author":"M Heiskala","year":"2022","unstructured":"Heiskala M, Joensuu K, Heikkila P. Core needle biopsy enhances the activity of the CCL2\/CCR2 pathway in the microenvironment of invasive breast cancer. Onco. 2022;2:1\u201318.","journal-title":"Onco"},{"key":"1013_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2889","volume":"13","author":"DL Holliday","year":"2011","unstructured":"Holliday DL, Speirs V. Choosing the right cell line for breast cancer research. Breast Cancer Res. 2011;13:215.","journal-title":"Breast Cancer Res"},{"key":"1013_CR43","doi-asserted-by":"publisher","first-page":"e105545","DOI":"10.1371\/journal.pone.0105545","volume":"9","author":"LM Cope","year":"2014","unstructured":"Cope LM, Fackler MJ, Lopez-Bujanda Z, Wolff AC, Visvanathan K, Gray JW, et al. Do breast cancer cell lines provide a relevant model of the patient tumor methylome. PLoS One. 2014;9:e105545.","journal-title":"PLoS One"},{"key":"1013_CR44","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.7150\/jca.18457","volume":"8","author":"X Dai","year":"2017","unstructured":"Dai X, Cheng H, Bai Z, Li J. Breast cancer cell line classification and its relevance with breast tumor subtyping. J Cancer. 2017;8:3131\u201341.","journal-title":"J Cancer"},{"key":"1013_CR45","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1158\/0008-5472.CAN-06-0825","volume":"66","author":"JS Nam","year":"2006","unstructured":"Nam JS, Kang MJ, Suchar AM, Shimamura T, Kohn EA, Michalowska AM, et al. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res. 2006;66:7176\u201384.","journal-title":"Cancer Res"},{"key":"1013_CR46","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10549-018-4760-8","volume":"170","author":"P Dutta","year":"2018","unstructured":"Dutta P, Sarkissyan M, Paico K, Wu Y, Vadgama JV. MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis. Breast Cancer Res Treat. 2018;170:477\u201386.","journal-title":"Breast Cancer Res Treat"},{"key":"1013_CR47","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1158\/1078-0432.CCR-07-0731","volume":"13","author":"RM Dwyer","year":"2007","unstructured":"Dwyer RM, Potter-Beirne SM, Harrington KA, Lowery AJ, Hennessy E, Murphy JM, et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res. 2007;13:5020\u20137.","journal-title":"Clin Cancer Res"},{"key":"1013_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jan\u00e9-Valbuena J, Kryukov GV, Lo CC, McDonald ER, et al. Next-generation characterization of the cancer cell line Encyclopedia. Nature. 2019;569:503\u20138.","journal-title":"Nature"},{"key":"1013_CR49","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/(SICI)1097-0215(19980717)77:2<306::AID-IJC22>3.0.CO;2-7","volume":"77","author":"A Treister","year":"1998","unstructured":"Treister A, Sagi-Assif O, Meer M, Smorodinsky NI, Anavi R, Golan I, et al. Expression of Ly-6, a marker for highly malignant murine tumor cells, is regulated by growth conditions and stress. Int J Cancer. 1998;77:306\u201313.","journal-title":"Int J Cancer"},{"key":"1013_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0165-2478(99)00043-7","volume":"68","author":"E Neumark","year":"1999","unstructured":"Neumark E, Anavi R, Witz IP, Ben-Baruch A. MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells. Immunol Lett. 1999;68:141\u20136.","journal-title":"Immunol Lett"},{"key":"1013_CR51","doi-asserted-by":"publisher","first-page":"e58791","DOI":"10.1371\/journal.pone.0058791","volume":"8","author":"T Yoshimura","year":"2013","unstructured":"Yoshimura T, Howard OM, Ito T, Kuwabara M, Matsukawa A, Chen K, et al. Monocyte chemoattractant protein-1\/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One. 2013;8:e58791.","journal-title":"PLoS One"},{"key":"1013_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/cancers7010143","volume":"7","author":"AM Santander","year":"2015","unstructured":"Santander AM, Lopez-Ocejo O, Casas O, Agostini T, Sanchez L, Lamas-Basulto E, et al. Paracrine interactions between adipocytes and tumor cells recruit and modify macrophages to the mammary tumor microenvironment: the role of obesity and inflammation in breast adipose tissue. Cancers. 2015;7:143\u201378.","journal-title":"Cancers"},{"key":"1013_CR53","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41556-019-0373-7","volume":"21","author":"IS Kim","year":"2019","unstructured":"Kim IS, Gao Y, Welte T, Wang H, Liu J, Janghorban M, et al. Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nat Cell Biol. 2019;21:1113\u201326.","journal-title":"Nat Cell Biol"},{"key":"1013_CR54","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.4049\/jimmunol.179.5.2851","volume":"179","author":"TJ Stewart","year":"2007","unstructured":"Stewart TJ, Abrams SI. Altered immune function during long-term host-tumor interactions can be modulated to retard autochthonous neoplastic growth. J Immunol. 2007;179:2851\u20139.","journal-title":"J Immunol"},{"key":"1013_CR55","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/1097-0142(195209)5:5<979::AID-CNCR2820050514>3.0.CO;2-J","volume":"5","author":"K Sugiura","year":"1952","unstructured":"Sugiura K, Stock CC. Studies in a tumor spectrum. II. The effect of 2,4,6-triethylenimino-s-triazine on the growth of a variety of mouse and rat tumors. Cancer. 1952;5:979\u201391.","journal-title":"Cancer"},{"key":"1013_CR56","doi-asserted-by":"publisher","first-page":"8074","DOI":"10.1002\/cam4.3295","volume":"9","author":"A Le Naour","year":"2020","unstructured":"Le Naour A, Rossary A, Vasson MP. EO771, is it a well-characterized cell line for mouse mammary cancer model? Limit and uncertainty. Cancer Med. 2020;9:8074\u201385.","journal-title":"Cancer Med"},{"key":"1013_CR57","first-page":"1399","volume":"52","author":"CJ Aslakson","year":"1992","unstructured":"Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992;52:1399\u2013405.","journal-title":"Cancer Res"},{"key":"1013_CR58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"1013_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11:R25.","journal-title":"Genome Biol"},{"key":"1013_CR60","unstructured":"Wickham, H. ggpol2: Elegant Graphic of data Analysis (Springer-Verlag New York, NY, 2016)."},{"key":"1013_CR61","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nature14403","volume":"520","author":"E Wagenblast","year":"2015","unstructured":"Wagenblast E, Soto M, Guti\u00e9rrez-\u00c1ngel S, Hartl CA, Gable AL, Maceli AR, et al. A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature. 2015;520:358\u201362.","journal-title":"Nature"},{"key":"1013_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-022-01557-5","volume":"24","author":"C Li","year":"2022","unstructured":"Li C, Yoshimura T, Tian M, Wang Y, Kondo T, Yamamoto KI, et al. Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer. Breast Cancer Res. 2022;24:60.","journal-title":"Breast Cancer Res"},{"key":"1013_CR63","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D","volume":"71","author":"SJ Youngs","year":"1997","unstructured":"Youngs SJ, Ali SA, Taub DD, Rees RC. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer. 1997;71:257\u201366.","journal-title":"Int J Cancer"},{"key":"1013_CR64","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1158\/0008-5472.CAN-11-3567","volume":"72","author":"A Tsuyada","year":"2012","unstructured":"Tsuyada A, Chow A, Wu J, Somlo G, Chu P, Loera S, et al. CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res. 2012;72:2768\u201379.","journal-title":"Cancer Res"},{"key":"1013_CR65","doi-asserted-by":"publisher","first-page":"36593","DOI":"10.1074\/jbc.M112.365999","volume":"287","author":"WB Fang","year":"2012","unstructured":"Fang WB, Jokar I, Zou A, Lambert D, Dendukuri P, Cheng N. CCL2\/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42\/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms. J Biol Chem. 2012;287:36593\u2013608.","journal-title":"J Biol Chem"},{"key":"1013_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88229-0","volume":"11","author":"WB Fang","year":"2021","unstructured":"Fang WB, Sofia Acevedo D, Smart C, Zinda B, Alissa N, Warren K, et al. Expression of CCL2\/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression. Sci Rep. 2021;11:8708.","journal-title":"Sci Rep"},{"key":"1013_CR67","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1158\/1541-7786.MCR-17-0308","volume":"16","author":"G Brummer","year":"2018","unstructured":"Brummer G, Acevedo DS, Hu Q, Portsche M, Fang WB, Yao M, et al. Chemokine signaling facilitates early-stage breast cancer survival and invasion through fibroblast-dependent mechanisms. Mol Cancer Res. 2018;16:296\u2013308.","journal-title":"Mol Cancer Res"},{"key":"1013_CR68","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10549-015-3324-4","volume":"150","author":"WB Fang","year":"2015","unstructured":"Fang WB, Yao M, Jokar I, Alhakamy N, Berkland C, Chen J, et al. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells. Breast Cancer Res Treat. 2015;150:309\u201320.","journal-title":"Breast Cancer Res Treat"},{"key":"1013_CR69","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1158\/1541-7786.MCR-18-0750","volume":"17","author":"M Yao","year":"2019","unstructured":"Yao M, Fang W, Smart C, Hu Q, Huang S, Alvarez N, et al. CCR2 chemokine receptors enhance growth and cell-cycle progression of breast cancer cells through SRC and PKC activation. Mol Cancer Res. 2019;17:604\u201317.","journal-title":"Mol Cancer Res"},{"key":"1013_CR70","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.canlet.2018.08.025","volume":"437","author":"S Lee","year":"2018","unstructured":"Lee S, Lee E, Ko E, Ham M, Lee HM, Kim ES, et al. Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-\u03b1 and MMP-9. Cancer Lett. 2018;437:25\u201334.","journal-title":"Cancer Lett"},{"key":"1013_CR71","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1158\/0008-5472.CAN-14-0992","volume":"75","author":"J Escamilla","year":"2015","unstructured":"Escamilla J, Schokrpur S, Liu C, Priceman SJ, Moughon D, Jiang Z, et al. CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy. Cancer Res. 2015;75:950\u201362.","journal-title":"Cancer Res"},{"key":"1013_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00888-2","volume":"20","author":"X Chen","year":"2022","unstructured":"Chen X, Yang M, Yin J, Li P, Zeng S, Zheng G, et al. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2\/AKT\/\u03b2-catenin signaling. Cell Commun Signal. 2022;20:92.","journal-title":"Cell Commun Signal"},{"key":"1013_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23750-4","volume":"12","author":"Q Kanyomse","year":"2022","unstructured":"Kanyomse Q, Le X, Tang J, Dai F, Mobet Y, Chen C, et al. KLF15 suppresses tumor growth and metastasis in Triple-Negative Breast Cancer by downregulating CCL2 and CCL7. Sci Rep. 2022;12:19026.","journal-title":"Sci Rep"},{"key":"1013_CR74","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.biocel.2003.11.001","volume":"36","author":"FP Barry","year":"2004","unstructured":"Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004;36:568\u201384.","journal-title":"Int J Biochem Cell Biol"},{"key":"1013_CR75","doi-asserted-by":"publisher","first-page":"101538","DOI":"10.1016\/j.smim.2021.101538","volume":"57","author":"M Siwicki","year":"2021","unstructured":"Siwicki M, Pittet MJ. Versatile neutrophil functions in cancer. Semin Immunol. 2021;57:101538.","journal-title":"Semin Immunol"},{"key":"1013_CR76","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ccr.2011.08.012","volume":"20","author":"Z Granot","year":"2011","unstructured":"Granot Z, Henke E, Comen EA, King TA, Norton L, Benezra R. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell. 2011;20:300\u201314.","journal-title":"Cancer Cell"},{"key":"1013_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3074-2","volume":"17","author":"N Lavender","year":"2017","unstructured":"Lavender N, Yang J, Chen SC, Sai J, Johnson CA, Owens P, et al. The Yin\/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo. BMC Cancer. 2017;17:88.","journal-title":"BMC Cancer"},{"key":"1013_CR78","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0167-5699(92)90008-U","volume":"13","author":"A Mantovani","year":"1992","unstructured":"Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today. 1992;13:265\u201370.","journal-title":"Immunol Today"},{"key":"1013_CR79","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/jcb.240210206","volume":"21","author":"ER Stanley","year":"1983","unstructured":"Stanley ER, Guilbert LJ, Tushinski RJ, Bartelmez SH. CSF-1-a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem. 1983;21:151\u20139.","journal-title":"J Cell Biochem"},{"key":"1013_CR80","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/07853899509031941","volume":"27","author":"BM Kacinski","year":"1995","unstructured":"Kacinski BM. CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med. 1995;27:79\u201385.","journal-title":"Ann Med"},{"key":"1013_CR81","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1084\/jem.193.6.727","volume":"193","author":"EY Lin","year":"2001","unstructured":"Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med. 2001;193:727\u201340.","journal-title":"J Exp Med"},{"key":"1013_CR82","first-page":"954","volume":"12","author":"CT Guy","year":"1992","unstructured":"Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992;12:954\u201361.","journal-title":"Mol Cell Biol"},{"key":"1013_CR83","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10585-005-2908-5","volume":"22","author":"AD Borowsky","year":"2005","unstructured":"Borowsky AD, Namba R, Young LJ, Hunter KW, Hodgson JG, Tepper CG, et al. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis. 2005;22:47\u201359.","journal-title":"Clin Exp Metastasis"},{"key":"1013_CR84","doi-asserted-by":"publisher","first-page":"e6562","DOI":"10.1371\/journal.pone.0006562","volume":"4","author":"B Qian","year":"2009","unstructured":"Qian B, Deng Y, Im JH, Muschel RJ, Zou Y, Li J, et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One. 2009;4:e6562.","journal-title":"PLoS One"},{"key":"1013_CR85","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475:222\u20135.","journal-title":"Nature"},{"key":"1013_CR86","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1084\/jem.20141836","volume":"212","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Qian BZ, Soong D, Cassetta L, Noy R, Sugano G, et al. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J Exp Med. 2015;212:1043\u201359.","journal-title":"J Exp Med"},{"key":"1013_CR87","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.phrs.2015.08.004","volume":"100","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Pollard JW. Therapeutic potential of chemokine signal inhibition for metastatic breast cancer. Pharm Res. 2015;100:266\u201370.","journal-title":"Pharm Res"},{"key":"1013_CR88","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1023\/A:1006461422273","volume":"65","author":"SJ Santner","year":"2001","unstructured":"Santner SJ, Dawson PJ, Tait L, Soule HD, Eliason J, Mohamed AN, et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat. 2001;65:101\u201310.","journal-title":"Breast Cancer Res Treat"},{"key":"1013_CR89","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.tranon.2017.06.009","volume":"10","author":"M Yao","year":"2017","unstructured":"Yao M, Smart C, Hu Q, Cheng N. Continuous delivery of neutralizing antibodies elevate CCL2 levels in mice bearing MCF10CA1d breast tumor xenografts. Transl Oncol. 2017;10:734\u201343.","journal-title":"Transl Oncol"},{"key":"1013_CR90","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","volume":"13","author":"Y H\u00fcsemann","year":"2008","unstructured":"H\u00fcsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell. 2008;13:58\u201368.","journal-title":"Cancer Cell"},{"key":"1013_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02481-5","volume":"9","author":"N Linde","year":"2018","unstructured":"Linde N, Casanova-Acebes M, Sosa MS, Mortha A, Rahman A, Farias E, et al. Macrophages orchestrate breast cancer early dissemination and metastasis. Nat Commun. 2018;9:21.","journal-title":"Nat Commun"},{"key":"1013_CR92","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1084\/jem.187.4.601","volume":"187","author":"B Lu","year":"1998","unstructured":"Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med. 1998;187:601\u20138.","journal-title":"J Exp Med"},{"key":"1013_CR93","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.4049\/jimmunol.0802812","volume":"183","author":"M Takahashi","year":"2009","unstructured":"Takahashi M, Galligan C, Tessarollo L, Yoshimura T. Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A. J Immunol. 2009;183:3463\u201371.","journal-title":"J Immunol"},{"key":"1013_CR94","doi-asserted-by":"publisher","first-page":"12053","DOI":"10.1073\/pnas.94.22.12053","volume":"94","author":"WA Kuziel","year":"1997","unstructured":"Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA. 1997;94:12053\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1013_CR95","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1172\/JCI119798","volume":"100","author":"L Boring","year":"1997","unstructured":"Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest. 1997;100:2552\u201361.","journal-title":"J Clin Invest"},{"key":"1013_CR96","doi-asserted-by":"publisher","first-page":"e25474","DOI":"10.4161\/onci.25474","volume":"2","author":"M Li","year":"2013","unstructured":"Li M, Knight DA, Snyder LA, Smyth MJ, Stewart TJ. A role for CCL2 in both tumor progression and immunosurveillance. Oncoimmunology. 2013;2:e25474.","journal-title":"Oncoimmunology"},{"key":"1013_CR97","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1038\/s41388-019-1141-7","volume":"39","author":"G Brummer","year":"2020","unstructured":"Brummer G, Fang W, Smart C, Zinda B, Alissa N, Berkland C, et al. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. Oncogene. 2020;39:2275\u201389.","journal-title":"Oncogene"},{"key":"1013_CR98","doi-asserted-by":"publisher","first-page":"10578","DOI":"10.1073\/pnas.89.22.10578","volume":"89","author":"CT Guy","year":"1992","unstructured":"Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA. 1992;89:10578\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1013_CR99","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325:612\u20136.","journal-title":"Science"},{"key":"1013_CR100","doi-asserted-by":"publisher","first-page":"e0165595","DOI":"10.1371\/journal.pone.0165595","volume":"11","author":"X Chen","year":"2016","unstructured":"Chen X, Wang Y, Nelson D, Tian S, Mulvey E, Patel B, et al. CCL2\/CCR2 regulates the tumor microenvironment in HER-2\/neu-driven mammary carcinomas in mice. PLoS One. 2016;11:e0165595.","journal-title":"PLoS One"},{"key":"1013_CR101","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1126\/science.1150224","volume":"319","author":"D Gao","year":"2008","unstructured":"Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science. 2008;319:195\u20138.","journal-title":"Science"},{"key":"1013_CR102","first-page":"3174","volume":"38","author":"DL Dexter","year":"1978","unstructured":"Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R, Heppner GH. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res. 1978;38:3174\u201381.","journal-title":"Cancer Res"},{"key":"1013_CR103","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/bcr77","volume":"2","author":"GH Heppner","year":"2000","unstructured":"Heppner GH, Miller FR, Shekhar PM. Nontransgenic models of breast cancer. Breast Cancer Res. 2000;2:331\u20134.","journal-title":"Breast Cancer Res"},{"key":"1013_CR104","doi-asserted-by":"publisher","first-page":"657158","DOI":"10.3389\/fcell.2021.657158","volume":"9","author":"P Gu","year":"2021","unstructured":"Gu P, Sun M, Li L, Yang Y, Jiang Z, Ge Y, et al. Breast tumor-derived exosomal MicroRNA-200b-3p promotes specific organ metastasis through regulating CCL2 expression in lung epithelial cells. Front Cell Dev Biol. 2021;9:657158.","journal-title":"Front Cell Dev Biol"},{"key":"1013_CR105","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1158\/0008-5472.CAN-09-4080","volume":"70","author":"MI Torres-Arzayus","year":"2010","unstructured":"Torres-Arzayus MI, Zhao J, Bronson R, Brown M. Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation. Cancer Res. 2010;70:4102\u201311.","journal-title":"Cancer Res"},{"key":"1013_CR106","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nature13862","volume":"515","author":"L Bonapace","year":"2014","unstructured":"Bonapace L, Coissieux MM, Wyckoff J, Mertz KD, Varga Z, Junt T, et al. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature. 2014;515:130\u20133.","journal-title":"Nature"},{"key":"1013_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0796-z","volume":"19","author":"X Sun","year":"2017","unstructured":"Sun X, Glynn DJ, Hodson LJ, Huo C, Britt K, Thompson EW, et al. CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model. Breast Cancer Res. 2017;19:4.","journal-title":"Breast Cancer Res"},{"key":"1013_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27108-8","volume":"12","author":"A Rogic","year":"2021","unstructured":"Rogic A, Pant I, Grumolato L, Fernandez-Rodriguez R, Edwards A, Das S, et al. High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer. Nat Commun. 2021;12:6889.","journal-title":"Nat Commun"},{"key":"1013_CR109","doi-asserted-by":"crossref","unstructured":"Tarek A, Mohamed HT, El-Sharkawy AA, El-Sayed SK, Hirshon JM, Woodward WA, et al. Differential gene expression of fresh tissue and patient-derived explants\u2019 matricellular proteins augment inflammatory breast cancer metastasis: the possible role of IL-6 and MCP-1. QJM hcac284 (2023).","DOI":"10.1093\/qjmed\/hcac284"},{"key":"1013_CR110","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","volume":"6","author":"RE Coleman","year":"2020","unstructured":"Coleman RE, Croucher PI, Padhani AR, Cl\u00e9zardin P, Chow E, Fallon M, et al. Bone metastases. Nat Rev Dis Prim. 2020;6:83.","journal-title":"Nat Rev Dis Prim"},{"key":"1013_CR111","doi-asserted-by":"publisher","first-page":"482","DOI":"10.21037\/atm.2020.03.55","volume":"8","author":"JF Huang","year":"2020","unstructured":"Huang JF, Shen J, Li X, Rengan R, Silvestris N, Wang M, et al. Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study. Ann Transl Med. 2020;8:482.","journal-title":"Ann Transl Med"},{"key":"1013_CR112","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10585-009-9281-8","volume":"26","author":"M Takahashi","year":"2009","unstructured":"Takahashi M, Miyazaki H, Furihata M, Sakai H, Konakahara T, Watanabe M, et al. Chemokine CCL2\/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model. Clin Exp Metastasis. 2009;26:817\u201328.","journal-title":"Clin Exp Metastasis"},{"key":"1013_CR113","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10585-008-9163-5","volume":"25","author":"M Takahashi","year":"2008","unstructured":"Takahashi M, Furihata M, Akimitsu N, Watanabe M, Kaul S, Yumoto N, et al. A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1. Clin Exp Metastasis. 2008;25:517\u201329.","journal-title":"Clin Exp Metastasis"},{"key":"1013_CR114","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature15376","volume":"527","author":"L Zhang","year":"2015","unstructured":"Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527:100\u20134.","journal-title":"Nature"},{"key":"1013_CR115","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1172\/JCI91553","volume":"127","author":"S Wang","year":"2017","unstructured":"Wang S, Liang K, Hu Q, Li P, Song J, Yang Y, et al. JAK2-binding long noncoding RNA promotes breast cancer brain metastasis. J Clin Invest. 2017;127:4498\u2013515.","journal-title":"J Clin Invest"},{"key":"1013_CR116","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.4049\/jimmunol.170.8.4139","volume":"170","author":"GH Boekhoudt","year":"2003","unstructured":"Boekhoudt GH, Guo Z, Beresford GW, Boss JM. Communication between NF-kappa B and Sp1 controls histone acetylation within the proximal promoter of the monocyte chemoattractant protein 1 gene. J Immunol. 2003;170:4139\u201347.","journal-title":"J Immunol"},{"key":"1013_CR117","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/sj.onc.1203412","volume":"19","author":"PC Cogswell","year":"2000","unstructured":"Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2\/p52 and for Bcl-3. Oncogene. 2000;19:1123\u201331.","journal-title":"Oncogene"},{"key":"1013_CR118","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1515\/bmc-2014-0022","volume":"5","author":"N Kiguchi","year":"2014","unstructured":"Kiguchi N, Saika F, Kobayashi Y, Kishioka S. Epigenetic regulation of CC-chemokine ligand 2 in non-resolving inflammation. Biomol Concepts. 2014;5:265\u201373.","journal-title":"Biomol Concepts"},{"key":"1013_CR119","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.canlet.2020.11.034","volume":"499","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Wang Z, Wei S, Liu Z, Chen G. Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer. Cancer Lett. 2021;499:148\u201363.","journal-title":"Cancer Lett"},{"key":"1013_CR120","doi-asserted-by":"publisher","first-page":"e0121281","DOI":"10.1371\/journal.pone.0121281","volume":"10","author":"S Mazumdar","year":"2015","unstructured":"Mazumdar S, Arendt LM, Phillips S, Sedic M, Kuperwasser C, Gill G. CoREST1 promotes tumor formation and tumor-stroma interactions in a mouse model of breast cancer. PLoS One. 2015;10:e0121281.","journal-title":"PLoS One"},{"key":"1013_CR121","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15:509\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1013_CR122","doi-asserted-by":"publisher","first-page":"852","DOI":"10.15252\/emmm.201707779","volume":"9","author":"MV Iorio","year":"2017","unstructured":"Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2017;9:852.","journal-title":"EMBO Mol Med"},{"key":"1013_CR123","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1007\/s00018-015-1925-z","volume":"72","author":"P Hartmann","year":"2015","unstructured":"Hartmann P, Schober A, Weber C. Chemokines and microRNAs in atherosclerosis. Cell Mol Life Sci. 2015;72:3253\u201366.","journal-title":"Cell Mol Life Sci"},{"key":"1013_CR124","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.yexcr.2017.01.001","volume":"351","author":"X Li","year":"2017","unstructured":"Li X, Fan Q, Li J, Song J, Gu Y. MiR-124 down-regulation is critical for cancer-associated fibroblasts-enhanced tumor growth of oral carcinoma. Exp Cell Res. 2017;351:100\u20138.","journal-title":"Exp Cell Res"},{"key":"1013_CR125","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1076997","volume":"298","author":"R Cao","year":"2002","unstructured":"Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science. 2002;298:1039\u201343.","journal-title":"Science"},{"key":"1013_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0817-6","volume":"19","author":"F Beca","year":"2017","unstructured":"Beca F, Kensler K, Glass B, Schnitt SJ, Tamimi RM, Beck AH. EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses\u2019 Health Studies. Breast Cancer Res. 2017;19:21.","journal-title":"Breast Cancer Res"},{"key":"1013_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05169-x","volume":"13","author":"YF Wang","year":"2022","unstructured":"Wang YF, Yu L, Hu ZL, Fang YF, Shen YY, Song MF, et al. Regulation of CCL2 by EZH2 affects tumor-associated macrophages polarization and infiltration in breast cancer. Cell Death Dis. 2022;13:748.","journal-title":"Cell Death Dis"},{"key":"1013_CR128","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/ncb2690","volume":"15","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y, et al. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol. 2013;15:284\u201394.","journal-title":"Nat Cell Biol"},{"key":"1013_CR129","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172:393\u2013407.","journal-title":"Cell"},{"key":"1013_CR130","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1158\/0008-5472.CAN-12-0653","volume":"73","author":"JM Low-Marchelli","year":"2013","unstructured":"Low-Marchelli JM, Ardi VC, Vizcarra EA, van Rooijen N, Quigley JP, Yang J. Twist1 induces CCL2 and recruits macrophages to promote angiogenesis. Cancer Res. 2013;73:662\u201371.","journal-title":"Cancer Res"},{"key":"1013_CR131","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2337\/db09-0997","volume":"59","author":"AT Pettersson","year":"2010","unstructured":"Pettersson AT, Laurencikiene J, Mejhert N, N\u00e4slund E, Bouloumi\u00e9 A, Dahlman I, et al. A possible inflammatory role of twist1 in human white adipocytes. Diabetes. 2010;59:564\u201371.","journal-title":"Diabetes"},{"key":"1013_CR132","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1073\/pnas.012425299","volume":"99","author":"Y Ino","year":"2002","unstructured":"Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA. 2002;99:365\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1013_CR133","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s13402-015-0226-8","volume":"38","author":"T Yoda","year":"2015","unstructured":"Yoda T, McNamara KM, Miki Y, Onodera Y, Takagi K, Nakamura Y, et al. KLF15 in breast cancer: a novel tumor suppressor. Cell Oncol. 2015;38:227\u201335.","journal-title":"Cell Oncol"},{"key":"1013_CR134","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fcell.2020.00025","volume":"8","author":"EH van Schie","year":"2020","unstructured":"van Schie EH, van Amerongen R. Aberrant WNT\/CTNNB1 signaling as a therapeutic target in human breast cancer: weighing the evidence. Front Cell Dev Biol. 2020;8:25.","journal-title":"Front Cell Dev Biol"},{"key":"1013_CR135","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1046\/j.1365-2168.2000.01513.x","volume":"87","author":"BP Wijnhoven","year":"2000","unstructured":"Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg. 2000;87:992\u20131005.","journal-title":"Br J Surg"},{"key":"1013_CR136","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/ijc.21291","volume":"118","author":"M Mestdagt","year":"2006","unstructured":"Mestdagt M, Polette M, Buttice G, No\u00ebl A, Ueda A, Foidart JM, et al. Transactivation of MCP-1\/CCL2 by beta-catenin\/TCF-4 in human breast cancer cells. Int J Cancer. 2006;118:35\u201342.","journal-title":"Int J Cancer"},{"key":"1013_CR137","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1038\/s41388-021-01986-0","volume":"40","author":"F Zhang","year":"2021","unstructured":"Zhang F, Li P, Liu S, Yang M, Zeng S, Deng J, et al. \u03b2-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cells. Oncogene. 2021;40:5854\u201365.","journal-title":"Oncogene"},{"key":"1013_CR138","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.semcancer.2019.02.001","volume":"59","author":"V \u00c1lvarez-Garcia","year":"2019","unstructured":"\u00c1lvarez-Garcia V, Tawil Y, Wise HM, Leslie NR. Mechanisms of PTEN loss in cancer: It\u2019s all about diversity. Semin Cancer Biol. 2019;59:66\u201379.","journal-title":"Semin Cancer Biol"},{"key":"1013_CR139","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-3-030-55031-8_12","volume":"1287","author":"Q Shen","year":"2021","unstructured":"Shen Q, Reedijk M. Notch signaling and the breast cancer microenvironment. Adv Exp Med Biol. 2021;1287:183\u2013200.","journal-title":"Adv Exp Med Biol"},{"key":"1013_CR140","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1158\/2159-8290.CD-17-0037","volume":"7","author":"Q Shen","year":"2017","unstructured":"Shen Q, Cohen B, Zheng W, Rahbar R, Martin B, Murakami K, et al. Notch shapes the innate immunophenotype in breast cancer. Cancer Disco. 2017;7:1320\u201335.","journal-title":"Cancer Disco"},{"key":"1013_CR141","doi-asserted-by":"publisher","first-page":"e2101592118","DOI":"10.1073\/pnas.2101592118","volume":"118","author":"A Jaiswal","year":"2021","unstructured":"Jaiswal A, Murakami K, Elia A, Shibahara Y, Done SJ, Wood SA, et al. Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer. Proc Natl Acad Sci USA. 2021;118:e2101592118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1013_CR142","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1172\/JCI78782","volume":"125","author":"K Yumimoto","year":"2015","unstructured":"Yumimoto K, Akiyoshi S, Ueo H, Sagara Y, Onoyama I, Ueo H, et al. F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner. J Clin Invest. 2015;125:621\u201335.","journal-title":"J Clin Invest"},{"key":"1013_CR143","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.humpath.2007.06.012","volume":"39","author":"H Liu","year":"2008","unstructured":"Liu H, Fan Q, Zhang Z, Li X, Yu H, Meng F. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers. Hum Pathol. 2008;39:167\u201374.","journal-title":"Hum Pathol"},{"key":"1013_CR144","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1245\/s10434-011-2032-5","volume":"19","author":"SP Bagaria","year":"2012","unstructured":"Bagaria SP, Ray PS, Wang J, Kropcho L, Chung A, Sim MS, et al. Prognostic value of basal phenotype in HER2-overexpressing breast cancer. Ann Surg Oncol. 2012;19:935\u201340.","journal-title":"Ann Surg Oncol"},{"key":"1013_CR145","doi-asserted-by":"publisher","first-page":"9008","DOI":"10.3390\/ijms21239008","volume":"21","author":"F Weinberg","year":"2020","unstructured":"Weinberg F, Peckys DB, de Jonge N. EGFR Expression in HER2-driven breast cancer cells. Int J Mol Sci. 2020;21:9008.","journal-title":"Int J Mol Sci"},{"key":"1013_CR146","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/ijms24021443","volume":"24","author":"D You","year":"2023","unstructured":"You D, Kim H, Jeong Y, Yoon SY, Lo E, Kim S, et al. Tumorigenicity of EGFR- and\/or HER2-positive breast cancers is mediated by recruitment of tumor-associated macrophages. Int J Mol Sci. 2023;24:1443.","journal-title":"Int J Mol Sci"},{"key":"1013_CR147","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361\u201371.","journal-title":"Nat Rev Cancer"},{"key":"1013_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","volume":"43","author":"D Cruceriu","year":"2020","unstructured":"Cruceriu D, Baldasici O, Balacescu O, Berindan-Neagoe I. The dual role of tumor necrosis factor-alpha (TNF-\u03b1) in breast cancer: molecular insights and therapeutic approaches. Cell Oncol. 2020;43:1\u201318.","journal-title":"Cell Oncol"},{"key":"1013_CR149","doi-asserted-by":"publisher","first-page":"e0175558","DOI":"10.1371\/journal.pone.0175558","volume":"12","author":"D Bauer","year":"2017","unstructured":"Bauer D, Redmon N, Mazzio E, Soliman KF. Apigenin inhibits TNF\u03b1\/IL-1\u03b1-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells. PLoS One. 2017;12:e0175558.","journal-title":"PLoS One"},{"key":"1013_CR150","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2174\/138945010792006799","volume":"11","author":"JE Goldberg","year":"2010","unstructured":"Goldberg JE, Schwertfeger KL. Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics. Curr Drug Targets. 2010;11:1133\u201346.","journal-title":"Curr Drug Targets"},{"key":"1013_CR151","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41568-021-00413-6","volume":"22","author":"DVF Tauriello","year":"2022","unstructured":"Tauriello DVF, Sancho E, Batlle E. Overcoming TGF\u03b2-mediated immune evasion in cancer. Nat Rev Cancer. 2022;22:25\u201344.","journal-title":"Nat Rev Cancer"},{"key":"1013_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2224","volume":"11","author":"MH Barcellos-Hoff","year":"2009","unstructured":"Barcellos-Hoff MH, Akhurst RJ. Transforming growth factor-beta in breast cancer: too much, too late. Breast Cancer Res. 2009;11:202.","journal-title":"Breast Cancer Res"},{"key":"1013_CR153","doi-asserted-by":"publisher","first-page":"a003277","DOI":"10.1101\/cshperspect.a003277","volume":"3","author":"H Moses","year":"2011","unstructured":"Moses H, Barcellos-Hoff MH. TGF-beta biology in mammary development and breast cancer. Cold Spring Harb Perspect Biol. 2011;3:a003277.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1013_CR154","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.imbio.2017.10.031","volume":"223","author":"PK Mandal","year":"2018","unstructured":"Mandal PK, Biswas S, Mandal G, Purohit S, Gupta A, Majumdar Giri A, et al. CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-\u03b2-induced breast cancer progression. Immunobiology. 2018;223:151\u201361.","journal-title":"Immunobiology"},{"key":"1013_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93561-6","volume":"11","author":"AM Gorbacheva","year":"2021","unstructured":"Gorbacheva AM, Uvarova AN, Ustiugova AS, Bhattacharyya A, Korneev KV, Kuprash DV, et al. EGR1 and RXRA transcription factors link TGF-\u03b2 pathway and CCL2 expression in triple negative breast cancer cells. Sci Rep. 2021;11:14120.","journal-title":"Sci Rep"},{"key":"1013_CR156","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th\u00fcrlimann B, Senn HJ, et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736\u201347.","journal-title":"Ann Oncol"},{"key":"1013_CR157","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1158\/1078-0432.CCR-15-0204","volume":"21","author":"S Svensson","year":"2015","unstructured":"Svensson S, Abrahamsson A, Rodriguez GV, Olsson AK, Jensen L, Cao Y, et al. CCL2 and CCL5 are novel therapeutic targets for estrogen-dependent breast cancer. Clin Cancer Res. 2015;21:3794\u2013805.","journal-title":"Clin Cancer Res"},{"key":"1013_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27810-6","volume":"8","author":"R Han","year":"2018","unstructured":"Han R, Gu S, Zhang Y, Luo A, Jing X, Zhao L, et al. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K\/AKT\/NF-\u03baB signaling. Sci Rep. 2018;8:9575.","journal-title":"Sci Rep"},{"key":"1013_CR159","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15:96\u2013109.","journal-title":"Nat Rev Cancer"},{"key":"1013_CR160","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.7150\/thno.42087","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Wang M, Gong T, Lei X, Hu T, Tian M, et al. A S100A14-CCL2\/CXCL5 signaling axis drives breast cancer metastasis. Theranostics. 2020;10:5687\u2013703.","journal-title":"Theranostics"},{"key":"1013_CR161","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fimmu.2016.00002","volume":"7","author":"T Yoshimura","year":"2016","unstructured":"Yoshimura T, Imamichi T, Weiss JM, Sato M, Li L, Matsukawa A, et al. Induction of monocyte chemoattractant proteins in macrophages via the production of granulocyte\/macrophage colony-stimulating factor by breast cancer cells. Front Immunol. 2016;7:2.","journal-title":"Front Immunol"},{"key":"1013_CR162","doi-asserted-by":"publisher","first-page":"e145296","DOI":"10.1172\/JCI145296","volume":"131","author":"X Su","year":"2021","unstructured":"Su X, Xu Y, Fox GC, Xiang J, Kwakwa KA, Davis JL, et al. Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment. J Clin Invest. 2021;131:e145296.","journal-title":"J Clin Invest"},{"key":"1013_CR163","doi-asserted-by":"publisher","first-page":"E6342","DOI":"10.3390\/ijms20246342","volume":"20","author":"T Yoshimura","year":"2019","unstructured":"Yoshimura T, Nakamura K, Li C, Fujisawa M, Shiina T, Imamura M, et al. Cancer cell-derived granulocyte-macrophage colony-stimulating factor is dispensable for the progression of 4T1 murine breast cancer. Int J Mol Sci. 2019;20:E6342.","journal-title":"Int J Mol Sci"},{"key":"1013_CR164","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/cimb43030122","volume":"43","author":"M Imamura","year":"2021","unstructured":"Imamura M, Li T, Li C, Fujisawa M, Mukaida N, Matsukawa A, et al. Crosstalk between cancer cells and fibroblasts for the production of monocyte Chemoattractant Protein-1 in the Murine 4T1 breast cancer. Curr Issues Mol Biol. 2021;43:1726\u201340.","journal-title":"Curr Issues Mol Biol"},{"key":"1013_CR165","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"1013_CR166","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10549-011-1410-9","volume":"131","author":"SM Potter","year":"2012","unstructured":"Potter SM, Dwyer RM, Hartmann MC, Khan S, Boyle MP, Curran CE, et al. Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo. Breast Cancer Res Treat. 2012;131:401\u201311.","journal-title":"Breast Cancer Res Treat"},{"key":"1013_CR167","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/0092-8674(83)90037-5","volume":"33","author":"BH Cochran","year":"1983","unstructured":"Cochran BH, Reffel AC, Stiles CD. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell. 1983;33:939\u201347.","journal-title":"Cell"},{"key":"1013_CR168","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.1073\/pnas.84.16.5763","volume":"84","author":"DA Bronzert","year":"1987","unstructured":"Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB, et al. Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci USA. 1987;84:5763\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1013_CR169","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","volume":"25","author":"F Balkwill","year":"2006","unstructured":"Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25:409\u201316.","journal-title":"Cancer Metastasis Rev"},{"key":"1013_CR170","doi-asserted-by":"publisher","first-page":"E2155","DOI":"10.3390\/ijms19082155","volume":"19","author":"R Bent","year":"2018","unstructured":"Bent R, Moll L, Grabbe S, Bros M. Interleukin-1 Beta-A friend or foe in malignancies. Int J Mol Sci. 2018;19:E2155.","journal-title":"Int J Mol Sci"},{"key":"1013_CR171","first-page":"1509","volume":"11","author":"P Mallmann","year":"1991","unstructured":"Mallmann P, Diedrich K, Mallmann R, Koenig UD, Krebs D. Determination of TNF alpha, interferon alpha, interleukin 2 and reactivity in the leucocyte migration inhibition test in breast cancer patients. Anticancer Res. 1991;11:1509\u201315.","journal-title":"Anticancer Res"},{"key":"1013_CR172","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2174\/1389201017666160301102713","volume":"17","author":"D Liu","year":"2016","unstructured":"Liu D, Wang X, Chen Z. Tumor Necrosis Factor-\u03b1, a regulator and therapeutic agent on breast cancer. Curr Pharm Biotechnol. 2016;17:486\u201394.","journal-title":"Curr Pharm Biotechnol"},{"key":"1013_CR173","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3389\/fimmu.2019.00757","volume":"10","author":"Y Liubomirski","year":"2019","unstructured":"Liubomirski Y, Lerrer S, Meshel T, Rubinstein-Achiasaf L, Morein D, Wiemann S, et al. Tumor-stroma-inflammation networks promote pro-metastatic chemokines and aggressiveness characteristics in triple-negative breast cancer. Front Immunol. 2019;10:757.","journal-title":"Front Immunol"},{"key":"1013_CR174","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cancers11020184","volume":"11","author":"LN Gilding","year":"2019","unstructured":"Gilding LN, Somervaille TCP. The diverse consequences of FOXC1 deregulation in cancer. Cancers. 2019;11:184.","journal-title":"Cancers"},{"key":"1013_CR175","doi-asserted-by":"publisher","first-page":"djv148","DOI":"10.1093\/jnci\/djv148","volume":"107","author":"TW Jensen","year":"2015","unstructured":"Jensen TW, Ray T, Wang J, Li X, Naritoku WY, Han B, et al. Diagnosis of basal-like breast cancer using a FOXC1-based assay. J Natl Cancer Inst. 2015;107:djv148.","journal-title":"J Natl Cancer Inst"},{"key":"1013_CR176","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.celrep.2015.09.063","volume":"13","author":"B Han","year":"2015","unstructured":"Han B, Qu Y, Jin Y, Yu Y, Deng N, Wawrowsky K, et al. FOXC1 activates smoothened-independent hedgehog signaling in basal-like breast cancer. Cell Rep. 2015;13:1046\u201358.","journal-title":"Cell Rep"},{"key":"1013_CR177","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1053\/j.gastro.2015.05.058","volume":"149","author":"W Huang","year":"2015","unstructured":"Huang W, Chen Z, Zhang L, Tian D, Wang D, Fan D, et al. Interleukin-8 induces expression of FOXC1 to promote transactivation of CXCR1 and CCL2 in hepatocellular carcinoma cell lines and formation of metastases in mice. Gastroenterology. 2015;149:1053\u201367.e14.","journal-title":"Gastroenterology"},{"key":"1013_CR178","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1634\/theoncologist.2015-0351","volume":"21","author":"V Simone","year":"2016","unstructured":"Simone V, D'Avenia M, Argentiero A, Felici C, Rizzo FM, De Pergola G, et al. Obesity and breast cancer: molecular interconnections and potential clinical applications. Oncologist. 2016;21:404\u201317.","journal-title":"Oncologist"},{"key":"1013_CR179","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10549-015-3318-2","volume":"150","author":"K Fujisaki","year":"2015","unstructured":"Fujisaki K, Fujimoto H, Sangai T, Nagashima T, Sakakibara M, Shiina N, et al. Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1. Breast Cancer Res Treat. 2015;150:255\u201363.","journal-title":"Breast Cancer Res Treat"},{"key":"1013_CR180","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/107999001750277862","volume":"21","author":"S Yokochi","year":"2001","unstructured":"Yokochi S, Hashimoto H, Ishiwata Y, Shimokawa H, Haino M, Terashima Y, et al. An anti-inflammatory drug, propagermanium, may target GPI-anchored proteins associated with an MCP-1 receptor, CCR2. J Interferon Cytokine Res. 2001;21:389\u201398.","journal-title":"J Interferon Cytokine Res"},{"key":"1013_CR181","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/cas.14306","volume":"111","author":"T Masuda","year":"2020","unstructured":"Masuda T, Noda M, Kogawa T, Kitagawa D, Hayashi N, Jomori T, et al. Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer. Cancer Sci. 2020;111:924\u201331.","journal-title":"Cancer Sci"},{"key":"1013_CR182","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.cell.2020.02.003","volume":"181","author":"PP Wong","year":"2020","unstructured":"Wong PP, Mu\u00f1oz-F\u00e9lix JM, Hijazi M, Kim H, Robinson SD, De Lux\u00e1n-Delgado B, et al. Cancer burden is controlled by mural cell-\u03b23-integrin regulated crosstalk with tumor cells. Cell. 2020;181:1346\u20131363.e21.","journal-title":"Cell"},{"key":"1013_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23946-8","volume":"12","author":"LG Lima","year":"2021","unstructured":"Lima LG, Ham S, Shin H, Chai E, Lek E, Lobb RJ, et al. Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution. Nat Commun. 2021;12:3543.","journal-title":"Nat Commun"},{"key":"1013_CR184","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.yexcr.2010.10.023","volume":"317","author":"T Yoshimura","year":"2011","unstructured":"Yoshimura T, Oppenheim JJ. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties. Exp Cell Res. 2011;317:674\u201384.","journal-title":"Exp Cell Res"},{"key":"1013_CR185","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-015-0696-6","volume":"32","author":"LP Wang","year":"2015","unstructured":"Wang LP, Cao J, Zhang J, Wang BY, Hu XC, Shao ZM, et al. The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells. Med Oncol. 2015;32:254.","journal-title":"Med Oncol"},{"key":"1013_CR186","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10549-010-0875-2","volume":"125","author":"XH Zeng","year":"2011","unstructured":"Zeng XH, Ou ZL, Yu KD, Feng LY, Yin WJ, Li J, et al. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes. Breast Cancer Res Treat. 2011;125:715\u201327.","journal-title":"Breast Cancer Res Treat"},{"key":"1013_CR187","doi-asserted-by":"publisher","first-page":"110734","DOI":"10.1016\/j.mehy.2021.110734","volume":"158","author":"X Zhong","year":"2021","unstructured":"Zhong X, Wang X, Sun Q. CCL2\/ACKR2 interaction participate in breast cancer metastasis especially in patients with altered lipid metabolism. Med Hypotheses. 2021;158:110734.","journal-title":"Med Hypotheses"},{"key":"1013_CR188","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1006\/bbrc.1999.0796","volume":"259","author":"BH Rovin","year":"1999","unstructured":"Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun. 1999;259:344\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1013_CR189","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00702-018-1936-7","volume":"125","author":"Y Wang","year":"2018","unstructured":"Wang Y, Huang S, Wu X, Wang Y, Jiang D. Correlation between MCP-1-2518A\/G polymorphism and the risk of Alzheimer\u2019s disease. J Neural Transm. 2018;125:1781\u20136.","journal-title":"J Neural Transm"},{"key":"1013_CR190","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1373\/clinchem.2004.041657","volume":"51","author":"G Ghilardi","year":"2005","unstructured":"Ghilardi G, Biondi ML, La Torre A, Battaglioli L, Scorza R. Breast cancer progression and host polymorphisms in the chemokine system: role of the macrophage chemoattractant protein-1 (MCP-1) -2518 G allele. Clin Chem. 2005;51:452\u20135.","journal-title":"Clin Chem"},{"key":"1013_CR191","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.4049\/jimmunol.151.6.3292","volume":"151","author":"I Sylvester","year":"1993","unstructured":"Sylvester I, Suffredini AF, Boujoukos AJ, Martich GD, Danner RL, Yoshimura T, et al. Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. Effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies, and immune complexes. J Immunol. 1993;151:3292\u20138.","journal-title":"J Immunol"},{"key":"1013_CR192","doi-asserted-by":"publisher","first-page":"107598","DOI":"10.1016\/j.intimp.2021.107598","volume":"101","author":"S Singh","year":"2021","unstructured":"Singh S, Anshita D, Ravichandiran V. MCP-1: Function, regulation, and involvement in disease. Int Immunopharmacol. 2021;101:107598.","journal-title":"Int Immunopharmacol"},{"key":"1013_CR193","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000077718","volume":"25","author":"A Lebrecht","year":"2004","unstructured":"Lebrecht A, Grimm C, Lantzsch T, Ludwig E, Hefler L, Ulbrich E, et al. Monocyte chemoattractant protein-1 serum levels in patients with breast cancer. Tumour Biol. 2004;25:14\u201317.","journal-title":"Tumour Biol"},{"key":"1013_CR194","first-page":"596","volume":"17","author":"J Wang","year":"2013","unstructured":"Wang J, He Q, Shao YG, Ji M. Chemokines fluctuate in the progression of primary breast cancer. Eur Rev Med Pharm Sci. 2013;17:596\u2013608.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"1013_CR195","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00428-018-2461-7","volume":"474","author":"M Heiskala","year":"2019","unstructured":"Heiskala M, Leidenius M, Joensuu K, Heikkil\u00e4 P. High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer. Virchows Arch. 2019;474:3\u201312.","journal-title":"Virchows Arch"},{"key":"1013_CR196","doi-asserted-by":"publisher","first-page":"2124390","DOI":"10.1155\/2018\/2124390","volume":"2018","author":"E Lubowicka","year":"2018","unstructured":"Lubowicka E, Przylipiak A, Zajkowska M, Pisk\u00f3r BM, Malinowski P, Fiedorowicz W, et al. Plasma chemokine CCL2 and its receptor CCR2 concentrations as diagnostic biomarkers for breast cancer patients. Biomed Res Int. 2018;2018:2124390.","journal-title":"Biomed Res Int"},{"key":"1013_CR197","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","volume":"19","author":"B Gy\u0151rffy","year":"2021","unstructured":"Gy\u0151rffy B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J. 2021;19:4101\u20139.","journal-title":"Comput Struct Biotechnol J"},{"key":"1013_CR198","doi-asserted-by":"publisher","first-page":"28697","DOI":"10.18632\/oncotarget.7376","volume":"7","author":"SY Lim","year":"2016","unstructured":"Lim SY, Yuzhalin AE, Gordon-Weeks AN, Muschel RJ. Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget. 2016;7:28697\u2013710.","journal-title":"Oncotarget"},{"key":"1013_CR199","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-017-0430-2","volume":"10","author":"L Yang","year":"2017","unstructured":"Yang L, Zhang Y. Tumor-associated macrophages: from basic research to clinical application. J Hematol Oncol. 2017;10:58.","journal-title":"J Hematol Oncol"},{"key":"1013_CR200","first-page":"726","volume":"1","author":"R Kolde","year":"2012","unstructured":"Kolde R. Pheatmap: pretty heatmaps. R Package Version. 2012;1:726.","journal-title":"R Package Version"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-023-01013-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-023-01013-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-023-01013-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T19:03:30Z","timestamp":1688065410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-023-01013-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":200,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["1013"],"URL":"https:\/\/doi.org\/10.1038\/s41423-023-01013-0","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}